+49 30 648 35 164 service@chameleon-pharma.com

Emerging Markets Forum: OTC Pharma go-to-market strategies, partnerships and market access

13 – 14 March 2017

Kempinski Hotel Bristol, Berlin, Germany


world color by Jurgen Appelo

world color by Jurgen Appelo

On March 13th & 14th 2017, OTC & Pharma global industry leaders will gather at the Kempinski Hotel in Berlin, to attend the Emerging Markets Forum. This unique two-day event, which is the biggest of its kind, will have a focus on the economic outlook for emerging markets, global product portfolio strategies and global go-to-market strategies for pharma and over-the-counter (OTC) products. Attendees include Pharma Executives, Key Regional Distributors, Area Managers and Market Access Executives amongst many others.

Over the two days there will be presentations and case studies given by different expert speakers from Russia, CIS, CEE, South Africa, Mexico and Caucasus. Reiner Christensen, CEO of Chameleon Pharma Consulting (Forum Knowledge Partner of the Emerging Markets Forum), is amongst the panel of speakers.

The forum will discuss how the MENA market is handling price declines and how these affect market access into the MENA region. Case studies will be presented and analysed for Latin American regions, namely Mexico. Market updates and overviews will be provided for Russia, EAEU and CEE. And there is also a segment planned for the South African market.

Not only does the event offer the opportunity to hear from a diverse range of industry experts, it also serves as a networking forum with business lunches and a cocktail reception inclusive in the event package. Additionally there is the possibility of having 1-to-1 meetings (must be pre-scheduled) with potential partners, local companies and country specific distributors.

-> Learn more about all new speakers here:

-> The update of the Forum agenda is available to download:


Featured image: Photo by Maheshkumar Painam on Unsplash


Related Posts

Our services


International Company Partner Identification

Licensing and

Product Potential & Country Analysis

International Business & Market Entry


Pharma Regulatory & Registration

Pharma Executive

International Strategy & Analysis

Market Reports and Analysis